Patent directory · USPTO A61K / A61P
Patents matching “Editas Medicine, Inc.”
20 pharma patents match "Editas Medicine, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 20 pharmaceutical patents matching "Editas Medicine, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12359223
Systems and methods for modulating chromosomal rearrangements
granted -
US 12331328
CRISPR/Cas9-mediated exon-skipping approach for USH2A-associated usher syndrome
granted -
US 12325854
Crispr-CPF1-related methods, compositions and components for cancer immunotherapy
granted -
US 12201699
Compositions and methods for promoting homology directed repair
granted -
US 12031132
Systems and methods for the treatment of hemoglobinopathies
granted -
US 11963982
CRISPR/RNA-guided nuclease systems and methods
granted -
US 11952408
HPV-specific binding molecules
granted -
US 11911415
CRISPR/Cas-related methods and compositions for improving transplantation
granted -
US 11851690
Systems and methods for the treatment of hemoglobinopathies
granted -
US 11834649
CRISPR/CAS-related methods and compositions for treating herpes simplex virus
granted -
US 11806408
Methods and compositions for treating cone-rod retinal dystrophy
granted -
US 11667911
Use of exonucleases to improve CRISPR/CAS-mediated genome editing
granted -
US 11597924
Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
granted -
US 11566263
Compositions and methods for treating CEP290 associated disease
granted -
US 11390884
Optimized CRISPR/cas9 systems and methods for gene editing in stem cells
granted -
US 11390861
CRISPR/cas-related methods and compositions for treating herpes simplex virus
granted -
US 11242525
CRISPR/CAS-related methods and compositions for treating sickle cell disease
granted -
US 11141493
Compositions and methods for treating CEP290-associated disease
granted -
US 11028388
CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa
granted -
US 11001844
CRISPR/Cas-related methods and compositions for treating herpes simplex virus
granted